Sortase A induces Th17-mediated and antibody-independent immunity to heterologous serotypes of group a streptococci

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Fan, Xin ^a   Wang, Xiaoshuang ^a   Li, Ning ^a   Cui, Honglian ^a   Hou, Baidong ^b   Gao, Bin ^a   Cleary, Paul Patrick ^c   Wang, Beinan ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; INTERLEUKIN 17; NEUTRALIZING ANTIBODY; SORTASE; SORTASE A; UNCLASSIFIED DRUG; AMINOACYLTRANSFERASE; BACTERIAL PROTEIN; CD19 ANTIGEN; CYSTEINE PROTEINASE; IL17A PROTEIN, MOUSE; STREPTOCOCCUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; CD4+ T LYMPHOCYTE; CELL TRANSPORT; CONTROLLED STUDY; FEMALE; GROUP A STREPTOCOCCAL INFECTION; IMMUNIZATION; LYMPHOID TISSUE; MOUSE; NASAL ASSOCIATED LYMPHOID TISSUE; NEUTROPHIL; NONHUMAN; NOSE; PROTEIN DEPLETION; SEROTYPE; STREPTOCOCCUS GROUP A; TH17 CELL; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; C57BL MOUSE; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; MICROBIOLOGY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TRANSPLANTATION;

STREPTOCOCCUS SP. 'GROUP A';

ADMINISTRATION, INTRANASAL; AMINOACYLTRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD19; B-LYMPHOCYTES; BACTERIAL PROTEINS; CYSTEINE ENDOPEPTIDASES; FEMALE; INTERLEUKIN-17; LYMPHOID TISSUE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; TH17 CELLS; VACCINATION;

EID: 84907189900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107638     Document Type: Article

References (36)

1. Kaplan EL, Johnson DR, Nanthapisud P, Sirilertpanrana S., Chumdermpadetsuk S (1992) A comparison of group A streptococcal serotypes isolated from the upper respiratory tract in the USA and Thailand: implications. Bull World Health Organ 70: 433-437.
2. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13: 470-511.
3. Fox EN, Waldman RH, Wittner M.K., Mauceri AA, Dorfman A. (1973) Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers. J Clin Invest 52: 1885-1892.
4. Massell BF, Honikman LH, Amezcua J. (1969) Rheumatic fever following streptococcal vaccination. Report of three cases. JAMA 207: 1115-1119.
5. Cossart P, Jonquieres R. (2000) Sortase, a universal target for therapeutic agents against gram-positive bacteria? Proc Natl Acad Sci U S A 97: 5013-5015.
6. Rodriguez-Ortega M.J., Norais N, Bensi G., Liberatori S, Capo S, et al (2006) Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol 24: 191-197.
7. Barnett TC, Scott J.R. (2002) Differential recognition of surface proteins in Streptococcus pyogenes by two sortase gene homologs. J Bacteriol 184: 2181-2191.
8. Race PR, Bentley ML, Melvin J.A., Crow A., Hughes RK, et al. (2009) Crystal structure of Streptococcus pyogenes sortase A: implications for sortase mechanism. J Biol Chem 284: 6924-6933.
9. Kharat AS, Tomasz A. (2003) Inactivation of the srtA gene affects localization of surface proteins and decreases adhesion of Streptococcus pneumoniae to human pharyngeal cells in vitro. Infect Immun 71: 2758-2765.
10. Garandeau C, Reglier-Poupet H, Dubail I., Beretti JL, Berche P, et al. (2002) The sortase SrtA of Listeria monocytogenes is involved in processing of internalin and in virulence. Infect Immun 70: 1382-1390.
11. Wang C, Li M, Feng Y., Zheng F, Dong Y, et al (2009) The involvement of sortase A in high virulence of STSS-causing Streptococcus suis serotype 2. Arch Microbiol 191: 23-33.
12. Mazmanian SK, Liu G, Jensen E.R., Lenoy E., Schneewind O. (2000) Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections. Proc Natl Acad Sci U S A 97: 5510-5515.
13. Movert E, Wu Y, Lambeau G., Touqui L, Areschoug T. (2011) A novel bacterial resistance mechanism against human group IIA-secreted phospholipase A2: role of Streptococcus pyogenes sortase A. J Immunol 187: 6437-6446.
14. Barnett TC, Patel AR, Scott J.R. (2004) A novel sortase, SrtC2, from Streptococcus pyogenes anchors a surface protein containing a QVPTGV motif to the cell wall. J Bacteriol 186: 5865-5875.
15. Wang B, Dileepan T, Briscoe S., Hyland KA, Kang J, et al. (2010) Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection. Proc Natl Acad Sci U S A 107: 5937-5942.
16. Dileepan T, Linehan JL, Moon J.J., Pepper M., Jenkins MK, et al. (2011) Robust antigen specific th17 T cell response to group A Streptococcus is dependent on IL-6 and intranasal route of infection. PLoS Pathog 7: e1002252.
17. Lu YJ, Gross J, Bogaert D., Finn A, Bagrade L, et al (2008) Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4: e1000159.
18. Chen K, McAleer JP, Lin Y, Paterson D.L., Zheng M., et al. (2011) Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity 35: 997-1009.
19. Hyland KA, Brennan R, Olmsted S.B., Rojas E., Murphy E, et al. (2009) The early interferon response of nasal-associated lymphoid tissue to Streptococcus pyogenes infection. FEMS Immunol Med Microbiol 55: 422-431.
20. Park HS, Francis KP, Yu J, Cleary P.P. (2003) Membranous cells in nasalassociated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol 171: 2532-2537.
21. Suvorov AN, Polyakova EM, McShan W.M., Ferretti J.J. (2009) Bacteriophage content of M49 strains of Streptococcus pyogenes. FEMS Microbiol Lett 294: 9-15.
22. Green NM, Zhang S, Porcella S.F., Nagiec MJ, Barbian KD, et al. (2005) Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis 192: 760-770.
23. Luk EY, Lo JY, Li A.Z., Lau MC, Cheung TK, et al. (2012) Scarlet fever epidemic, Hong Kong, 2011. Emerg Infect Dis 18: 1658-1661.
24. Lee JB, Jang JE, Song M.K., Chang J. (2009) Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens. PLoS One 4: e5190.
25. Kang H, Remington JS, Suzuki Y. (2000) Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. J Immunol 164: 2629-2634.
26. Kwinn LA, Nizet V. (2007) How group A Streptococcus circumvents host phagocyte defenses. Future Microbiol 2: 75-84.
27. Pelletier M, Maggi L, Micheletti A., Lazzeri E, Tamassia N, et al (2010) Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115: 335-343.
28. Polly SM, Waldman RH, High P, Wittner M.K., Dorfman A. (1975) Protective studies with a group A streptococcal M protein vaccine. II. Challange of volenteers after local immunization in the upper respiratory tract. J Infect Dis 131: 217-224.
29. Wannamaker LW, Denny FW, Perry W.D., Siegel AC, Rammelkamp CH, Jr. (1953) Studies on immunity to streptococcal infections in man. AMA Am J Dis Child 86: 347-348.
30. Guirguis N, Fraser DW, Facklam R.R., El Kholy A, Wannamaker L.W. (1982) Type-specific immunity and pharyngeal acquisition of group A Streptococcus. Am J Epidemiol 116: 933-939.
31. Quinn RW, Vander Zwaag R, Lowry P.N. (1985) Acquisition of group A streptococcal M protein antibodies. Pediatr Infect Dis 4: 374-378.
32. Ashbaugh CD, Moser TJ, Shearer M.H., White GL, Kennedy RC, et al. (2000) Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol 2: 283-292.
33. Raz A, Fischetti V.A. (2008) Sortase A localizes to distinct foci on the Streptococcus pyogenes membrane. Proc Natl Acad Sci U S A 105: 18549-18554.
34. Wilkinson TM, Li CK, Chui C.S., Huang AK, Perkins M, et al. (2012) Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 18: 274-280.
35. Misstear K, McNeela EA, Murphy A.G., Geoghegan JA, O'Keeffe KM, et al. (2014) Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureus. J Infect Dis 209: 1479-1484.
36. Basset A, Thompson CM, Hollingshead S.K., Briles DE, Ades EW, et al. (2007) Antibody-independent, CD4+ T-cell-dependent protection against pneumococ-cal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect Immun 75: 5460-5464.